R-ondansetron
Latest Information Update: 22 Feb 2006
At a glance
- Originator Sepracor
- Class Antiemetics
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Nausea and vomiting
Most Recent Events
- 22 Feb 2006 No development reported - Preclinical for Emesis in USA (unspecified route)
- 18 Apr 2001 Preclinical development for Emesis in USA (Unknown route)
- 08 Mar 2000 No-Development-Reported for Emesis in USA (Unknown route)